Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Committed to Global Health, Potential Positive Impact of PAX-101
Via Investor Brand Network
Exposures Product Safety
Tickers PXMD
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
Via Benzinga
Exposures COVID-19 Product Safety
Tickers BNTX MRNA NVAX PFE
CUSTICS Launches Hautuki as an OTC Product in Singapore
Via AB Newswire
Exposures Product Safety
OysterLink Poll Reveals Restaurant Workers Feel Pressured to Work While Sick
Via Newsfile
Exposures Product Safety
Positive Clinical Results with Promising Gene Therapy Treatment for Late Stage Lung Cancer; Life-Changing Developments for Cancer & Diabetes: GNPX
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
Via Benzinga
Exposures Product Safety
FDA Rejects MDMA for Mental Health Treatment After Identifying Flawed Study Data
Via PRLog
Topics Death
Exposures Death Product Safety
Tickers NYT
Austin singer-songwriter Nathan Hamilton returns with Not One Among Us, Oct. 11. A beautiful collab with Japanese musician/producer Shotaro Miyamoto
Via PRLog
Topics Product Recall Religion
Exposures Legal Product Safety Religion
Clene Inc.’s (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers and Long-term Survival in ALS Trials
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Fisker Recalls Nearly 8K Ocean SUVs Over Risks Of Reduced Braking Performance
Via Benzinga
Topics Bankruptcy Product Recall
Exposures Financial Legal Product Safety
GM's Autonomous Driving Unit Cruise Recalls All U.S. Vehicles Over Concerns Of Unexpected Braking: Auto Safety Regulator Closes Investigation
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers GM
CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials
Via Press Release Distribution Service
Exposures Product Safety
Tesla Recalls Over 9K Units Of Older Model X SUVs Over Concerns Of Cosmetic Trim Pieces On Roof Falling Off
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
Mentoring the Future: Aryn Hala’s Approach to Inspiring Young Culinary Talent
Via Zexprwire
Topics Product Recall
Exposures Legal Product Safety
A Commitment to Community Service and Leadership: Joaquín Antonio Perusquía Corres
Via Zexprwire
Topics Product Recall
Exposures Legal Product Safety
Regeneron Faces Setback With FDA Rejection Of Blood-Cancer Treatment
Via Benzinga
Exposures Product Safety
Tickers REGN
FDA’s Rejection of MDMA Therapy Draws Ire of Psychedelics Experts
Via Investor Brand Network
Exposures Product Safety
Johnson & Johnson Strikes $1.7B Deal To Acquire Heart-Tech Innovator V-Wave
Via Benzinga
Exposures Product Safety
Tickers AZN JNJ
BMW Recalls Nearly 721K Vehicles In US Over Short Circuit Worries: Both Gas And Hybrid Electric Cars Affected
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers BMWYY
AlgoDx Receives FDA Clearance for Sepsis Detection Software
Via EZ Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Bob Marley Film Where Michael Gandolfini Plays Iconic publicist Howard Bloom Goes #1 on Paramount Plus
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
Via Benzinga
Topics ETFs
Exposures COVID-19 Product Safety
Tickers BBP BNTX FDL FTXH
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
Via MarketBeat
Exposures COVID-19 Product Safety
Tickers BNTX MRK MRNA NVAX
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Reports on Status of Lead Drug Candidate Designed to Treat Concussion
Via Investor Brand Network
Exposures Product Safety
Tickers OGEN
FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose
Via Benzinga
Exposures Product Safety
Tickers BNTX
United Health Products Submits Response Letter to FDA
Via NewMediaWire
Exposures Product Safety
Tickers UEEC
FDA Rejects MDMA for Mental Health Treatment After Identifying Flawed Study Data
Via Press Release Distribution Service
Exposures Product Safety
Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment
Via Benzinga
Exposures Product Safety
Incyte Seeks Expanded FDA Approval For Lymphoma Drug After Releasing Promising Topline Data From Late-Stage Study
Via Benzinga
Exposures Product Safety
Tickers INCY
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.